ArticleCurrent medical research and opinion2018
Effect of ruxolitinib therapy on the quality-of-life of Japanese patients with myelofibrosis.
Kenji Oritani et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papertrialcites it